Goktas Aydin S, Kavak EE, Topcu A, Bayramgil A, Akgul F, Kahraman S, Aykan MB, Altıntas YE, Helvaci K, Urun Y, Bilici A, Seker M, Sendur MAN, Olmez OF, Acikgoz O, Cicin I. Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study. Biomol Biomed [Internet]. 2023Nov.3 [cited 2023Dec.11];23(6):1089–1095. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/9253